Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc Lowers FY 2012 Revenue Guidance; Lowers High End Of Prior FY 2012 EPS Guidance To A Range Below Analysts' Estimates; Reaffirms FY 2012 EBIT Guidance


Wednesday, 17 Oct 2012 07:00am EDT 

Quest Diagnostics Inc announced that for fiscal 2012, it expects revenues to grow approximately 0.5%, compared to the prior outlook of between 1% and 2%, earnings per diluted share (EPS) to be between $4.45 and $4.55, compared to the prior outlook of $4.45 to $4.60 and operating income as a percentage of revenues to approximate 18%, unchanged from the prior outlook. The Company reported net revenues of $7.511 billion in fiscal 2011. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $7.63 billion, EPS of $4.56 and EBIT of $1.36 billion for fiscal 2012. 

Company Quote

63.06
0.14 +0.22%
4:01pm EDT